【レポートの概要（一部）】
PART 01: Executive summary
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Disease overview
• Understanding the disease
PART 06: Pipeline analysis
PART 07: Market landscape
• Global multiple myeloma drugs market
• Five forces analysis
PART 08: Market segmentation by therapy
• Targeted therapy
• Biologic therapy
• Chemotherapy
• Others
PART 09: Geographical segmentation
• Multiple myeloma drugs market in Americas
• Multiple myeloma drugs market in EMEA
• Multiple myeloma drugs market in APAC
PART 10: Market drivers
• Growing demand for biologic therapies
• Paradigm shift toward the adoption of novel proteasome inhibitors
• Presence of large patient pool
PART 11: Impact of drivers
PART 12: Market challenges
• Growing popularity of complementary and alternative medicines (CAM)
• High costs affecting the adoption rates of multiple myeloma drugs
• Adverse effects of drugs
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Emergence of nanomedicine platform
• Advent of microRNA therapeutics
• Increasing inorganic growth strategies
PART 15: Vendor landscape
• Competitive scenario
PART 16: Key vendor analysis
• Amgen
• Celgene
• Johnson & Johnson
• Novartis
• Takeda Pharmaceuticals
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key customer segments of global multiple myeloma drugs market
Exhibit 03: Factors affecting the adoption rates of multiple myeloma drugs market
Exhibit 04: Pipeline landscape
Exhibit 05: Pipeline analysis
Exhibit 06: Global multiple myeloma drugs market snapshot
Exhibit 07: Global multiple myeloma drugs market 2016-2021 ($ billions)
Exhibit 08: Opportunity analysis of global multiple myeloma drugs market
Exhibit 09: Opportunity analysis in developed and emerging markets
Exhibit 10: Five forces analysis
Exhibit 11: Segmentation of global multiple myeloma drugs market by therapy 2016
Exhibit 12: Lifecycle analysis of segments in global multiple myeloma drugs market 2016
Exhibit 13: Segmentation of global multiple myeloma drugs market based on geography 2016 and 2021
Exhibit 14: Multiple myeloma drugs market revenue by geography 2016-2021 ($ billions)
Exhibit 15: Market scenario in Americas
Exhibit 16: Multiple myeloma drugs market in Americas 2016-2021 ($ billions)
Exhibit 17: Market scenario in EMEA
Exhibit 18: Multiple myeloma drugs market in EMEA 2016-2021 ($ billions)
Exhibit 19: Market scenario in APAC
Exhibit 20: Multiple myeloma drugs market in APAC 2016-2021 ($ billions)
Exhibit 21: Key drivers and challenges in APAC
Exhibit 22: Impact of drivers
Exhibit 23: Alternative therapies for multiple myeloma drugs
Exhibit 24: Forcefield analysis of drivers and challenges
Exhibit 25: Impact of drivers and challenges
Exhibit 26: Key factors driving the adoption of nanomedicine
Exhibit 27: Factors driving the adoption of miRNA therapeutics
Exhibit 28: Key deals in global multiple myeloma drugs market
Exhibit 29: Competitive structure analysis of global multiple myeloma drugs market 2015
Exhibit 30: Market share analysis in global multiple myeloma drugs market
Exhibit 31: Competitive analysis of global multiple myeloma drugs market
Exhibit 32: Market penetration of various multiple myeloma drugs manufacturers worldwide (2016)
Exhibit 33: Amgen: Key highlights
Exhibit 34: Amgen: Strength assessment
Exhibit 35: Amgen: Strategy assessment
Exhibit 36: Amgen: Opportunity assessment
Exhibit 37: Celgene: Key highlights
Exhibit 38: Celgene: Strength assessment
Exhibit 39: Celgene: Strategy assessment
Exhibit 40: Celgene: Opportunity assessment
Exhibit 41: Celgene: YoY revenue and growth rate of REVLIMID 2013-2015 ($ billions)
Exhibit 42: Celgene: YoY revenue and growth rate of POMALYST 2013-2015 ($ millions)
Exhibit 43: Celgene: YoY revenue and growth rate of THALOMID 2013-2015 ($ millions)
Exhibit 44: Johnson & Johnson: Key highlights
Exhibit 45: Johnson & Johnson: Strength assessment
Exhibit 46: Johnson & Johnson: Strategy assessment
Exhibit 47: Johnson & Johnson: Opportunity assessment
Exhibit 48: Johnson & Johnson: YoY global revenue comparison of VELCADE 2013-2015 ($ billions)
Exhibit 49: Novartis: Key highlights
Exhibit 50: Novartis: Strength assessment
Exhibit 51: Novartis: Strategy assessment
Exhibit 52: Novartis: Opportunity assessment
Exhibit 53: Takeda Pharmaceuticals: Key highlights
Exhibit 54: Takeda Pharmaceuticals: Strength assessment
Exhibit 55: Takeda Pharmaceuticals: Strategy assessment
Exhibit 56: Takeda Pharmaceuticals: Opportunity assessment
【レポート販売概要】
■ タイトル：多発性骨髄腫治療薬の世界市場2017-2021■ 英文：Global Multiple Myeloma Drugs Market 2017-2021
■ 発行日：2016年12月27日
■ 調査会社：Technavio
■ 商品コード：IRTNTR11277
■ 調査対象地域：グローバル
- 醸造用酵素の世界市場予測（～2023年）：アミラーゼ、β-グルカナーゼ、プロテアーゼ、キシラナーゼ、ALDC、ペクチナーゼThe brewing enzymes market is estimated at USD 352.1 million in 2018. It is projected to reach USD 484.7 million by 2023, at a CAGR of 6.6% from 2018, in terms of value. The use of enzymes has become increasingly important in the brewing industry, as they accelerate the chemical reaction without a change in their own structure. To enhance the brewing process, commercial exogenous enzymes are used …
- 医薬品リーダーシリーズ：医薬品製造受託機関（CMO）上位30社2016-2026In its updated report, visiongain provides revenues to 2026 for the world pharmaceutical contract manufacturing organisations (CMO) market. This report also analyses leading companies in pharmaceutical contract manufacturing. The demand for outsourced drug production has grown rapidly in the past 10 years. The world market for pharma contract manufacturing was worth $61.6bn in 2015, having grown b …
- 流量計の世界市場：タイプ別（差圧、正変位、超音波、タービン、磁気、コリオリ、渦、その他）、エンドユーザー別（水＆廃水、石油＆ガス、化学薬品、発電、パルプ＆紙、食品＆飲料、その他）The global flow meter market was valued at $7.3 billion in 2018, and is projected to reach $11.9 billion by 2026, growing at a CAGR of 6.3% from 2019 to 2026. A flow meter is a device or equipment used to measure the volume or mass of the gas or liquid. It is also known as a flow indicator, flow rate sensor, liquid meter, and flow gauge; that is dependent on its use in any particular industry. Flo …
- 嗅覚異常治療のグローバル臨床試験動向（2014年下半期）Olfactory Disorders Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Olfactory Disorders Global Clinical Trials Review, H2, 2014" provides data on the Olfactory Disorders clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Olfactory Disorders. It includes an overview of the trial numbers and their recru …
- Fulvic Acidの世界市場Fulvic Acid (CAS 479-66-3) Market Research Report 2013 presents comprehensive data on Fulvic acid markets globally and regionally (Europe, Asia, North America etc.) The Fulvic Acid (CAS 479-66-3) Market Research Report 2013 includes Fulvic acid description, covers its application areas and related patterns. It overviews Fulvic acid market, names Fulvic acid producers and indicates its suppliers. B …
- 炭素回収および隔離の世界市場展望2017-20276According to Stratistics MRC, the Global Carbon Capture and Sequestration market is accounted for $4.88 billion in 2017 and is expected to reach $16.90 billion by 2026 growing at a CAGR of 14.8% during the forecast period. Some of the key factors such as rising ecological concern, and growing demand for co2-eor techniques which is propelling the growth of the market. However, narrow adequate polic …
- 世界のナノテクノロジーを用いたドラッグデリバリー市場動向（2012-2016）TechNavio's analysts forecast the Global Nanotechnology Drug Delivery market to grow at a CAGR of 73.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to th …
- マイクロサーバの世界市場2015-2019About Micro Servers Micro servers are small server appliance with similar functionality as that of traditional servers. The concept of micro servers is similar to that of traditional blade servers, which essentially puts multiple servers into one physical chassis for shared power and cooling. A micro server includes in-built hardware, software, and operating system. Micro servers help to scale out …
- 血液型判定の世界市場2019-2023About this market In recent years, the increasing prevalence of chronic diseases such as diabetes and cancer among individuals is leading to a rising demand for early diagnosis for better patient care. Blood group testing is necessary for cancer patients, as the disease may require blood transfusion for treatment. Blood products such as platelets used for treating cancer patients have a shorter sh …
- エチレン・酢酸ビニル（EVA）の世界市場：VLEVA、LEVA、MEVA、HEVAThe global ethylene vinyl acetate (EVA) market size, in terms of value, is projected to reach USD 9.71 Billion by 2020, at a CAGR of 3.5% between 2015 and 2020. The high potential from the packaging and footwear & foam industry, increasing global demand for EVA in solar energy sector, and continuous expansion and merger & acquisition activities undertaken by different companies are the key factors …
- 皮膚科用薬剤の世界市場：皮膚感染症薬、皮膚炎薬、にきび薬、乾癬薬Dermatological drugs - new study showing you trends, partnerships, and predicted revenues Where is the market for dermatological drugs heading? What are the commercial prospects for this market? Visiongain’s new report shows you potential revenues and other trends to 2025, discussing data, opportunities and prospects. Our 310 page report provides 220 tables, charts, and graphs. Discover the most l …
- 輸血診断検査のグローバル市場動向2014This report provides a worldwide overview of the transfusion testing market, including estimates of facilities performing transfusion testing tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country.Contains 15 pages and 5 tables
- 自動車バイオセンサーの世界市場2016-2020About Biosensor A biosensor consists of a bio-response recognition component. It can be referred to as a bio-component with a transducer that converts a biological response into an electrical signal, which is then amplified, processed, and displayed on the display unit. The combination of the bio-component and the transducer is referred to as the biosensor. Technavio’s analysts forecast the global …
- 次世代9-1-1：プロバイダ及びソリューション2013（Next Generation 9-1-1: Providers and Solutions 2013）Next Generation 9-1-1 ( NG9-1-1) is an initiative that targets updating the 9-1-1 emergency service infrastructure in USA and Canada in order to improve public emergency communications services. The Improvement includes adding text messages, images, video and data beside the traditional phone calls for 9-1-1 service. What will be our future with Next Generation 9-1-1 applications and services? The …
- PGNiG SA：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013PGNiG SA Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary PGNiG SA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational data, …
